Overview

Non-invasive Measures of Distal Lung Disease in Asthmatics

Status:
Completed
Trial end date:
2007-09-01
Target enrollment:
Participant gender:
Summary
This is a Phase 4, single center study conducted in mild-to moderate asthmatics.
Phase:
Phase 4
Details
Lead Sponsor:
Teva Branded Pharmaceutical Products R&D, Inc.
Teva Branded Pharmaceutical Products, R&D Inc.
Treatments:
Beclomethasone
Fluticasone Propionate, Salmeterol Xinafoate Drug Combination
Fluticasone-Salmeterol Drug Combination